Jan. 22, 2020
- Ranked 3rd among pharmaceutical companies for sustainable leadership
- Recognized for environmental sustainability, equitable pricing strategies in low- and middle-income countries, and senior executive female representation
OSAKA,
Japan--(BUSINESS WIRE/AETOSWire)--
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named
in the Corporate Knights Global 100 Most Sustainable
Corporations in the World (Global 100) for the fifth consecutive year. Corporate
Knights assesses more than 7,300 companies against 21 key performance
indicators. It uses these indicators to determine the top 1% most sustainable
companies in the world, which are announced annually at the World Economic
Forum in Davos, Switzerland.
“Building
sustainable value is a fundamental part of the way we do business at Takeda, and
we are proud to be recognized as a global leader in sustainability,” said
Christophe Weber, President and CEO. “This recognition by Corporate
Knights is a testament to the strong foundation Takeda has laid and
the progress we have already achieved. We remain steadfast in our commitment to
realizing Better Health and a Brighter Future for all.”
Corporate
Knights highlighted
Takeda’s performance in the following areas:
- Significant year-on-year improvement in energy, water and greenhouse gas productivity scores.
- High marks for clean revenue, which measures revenue earned by providing access to medicine for top priority diseases in low- and middle-income countries through equitable pricing strategies.
- Three times the average score for female representation among senior executives.
In
addition to the Global 100 index, Takeda is recognized by many other
environmental, social and governance (ESG) investment valuations. As a
long-standing member of the United Nations Global Compact, Takeda’s
sustainability efforts are guided by key international targets, such as the
Sustainable Development Goals (SDGs).
|
Name of
Index or Rating |
Company/
Organization |
Country
|
History of
Inclusion |
|
Dow Jones Sustainability World Index
|
Dow Jones
|
U.S.
|
1st year
|
|
Dow Jones Sustainability Asia Pacific Index
|
Dow Jones
|
U.S.
|
10th year
|
|
FTSE4Good Developed Index
|
FTSE Russell
|
U.K.
|
15th consecutive year
|
|
MSCI ESG Leaders Index
|
MSCI
|
U.S.
|
10th consecutive year
|
|
Ethibel EXCELLENCE Investment Register
|
Forum Ethibel
|
BEL
|
Since July 2017
|
|
Prime Status
|
ISS-Oekom
|
GER
|
2nd consecutive year
|
|
Industry Mover Sustainability Yearbook Award
2019
|
RobecoSAM
|
CHE
|
Since February 2019
|
About
Takeda Pharmaceutical Company Limited
Takeda
Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) is a global, values-based,
R&D-driven biopharmaceutical leader headquartered in Japan, committed to
bringing Better Health and a Brighter Future to patients by translating science
into highly-innovative medicines. Takeda focuses its R&D efforts on four
therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology
(GI). We also make targeted R&D investments in Plasma-Derived Therapies and
Vaccines. We are focusing on developing highly innovative medicines that
contribute to making a difference in people's lives by advancing the frontier
of new treatment options and leveraging our enhanced collaborative R&D
engine and capabilities to create a robust, modality-diverse pipeline. Our
employees are committed to improving quality of life for patients and to
working with our partners in health care in approximately 80 countries.
For more information, visit www.takeda.com
For more information, visit www.takeda.com
About
Takeda’s Sustainable Value Report
Takeda’s
annual Sustainable Value Report showcases how the company is addressing the
world’s biggest challenges to sustainable development over the long term. Data
included are primarily non-financial, focusing on Takeda’s diverse CSR/ESG
(sustainability) commitments, as well as how CSR/ESG priorities are
inextricably linked to the company’s DNA. Takeda leverages such benchmarks as
the international integrated reporting framework of the International
Integrated Reporting Council (IIRC), United Nations Global Compact’s advanced
level assessment criteria, and Global Reporting Initiative (GRI) Standards to
create a comprehensive report that incorporates high standards of transparency
and disclosure, targeting a broad range of stakeholders.
For more information, visit https://www.takeda.com/corporate-responsibility/Sustainable-Value-Report/
For more information, visit https://www.takeda.com/corporate-responsibility/Sustainable-Value-Report/
View source version on
businesswire.com: https://www.businesswire.com/news/home/20200120005554/en/
*Source:
AETOSWire
Contacts
View
this news release online at:
http://www.businesswire.com/news/home/20200120005554/en
http://www.businesswire.com/news/home/20200120005554/en